Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00770757Phase 2Completed
A Phase 2 trial of pomalidomide in chronic graft-versus-host disease (cGVHD), sponsored by Washington University School of Medicine. Started Feb 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00770757.